Vaidya Sane Ayurved Laboratories Share Price

Vaidya Sane Ayurved Laboratories Investment Rating

• Master Rating:

• Vaidya Sane Ayurved Laboratories has an operating revenue of Rs. 264.71 Cr. on a trailing 12-month basis. An annual revenue growth of 44% is outstanding, Pre-tax margin of 6% is okay, ROE of 9% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 33% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It has recently broken out of a base in its weekly chart and is trading around -4% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 85 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 54 indicates it belongs to a fair industry group of Medical-Hospitals and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.